Nadal D - Search Results

1

Lünemann A, Rowe M, Nadal D. Lünemann A, et al. Among authors: nadal d. Curr Top Microbiol Immunol. 2015;391:265-87. doi: 10.1007/978-3-319-22834-1_9. Curr Top Microbiol Immunol. 2015. PMID: 26428378 Review.

2

A distinct subpopulation of human NK cells restricts B cell transformation by EBV.

Lünemann A, Vanoaica LD, Azzi T, Nadal D, Münz C. Lünemann A, et al. Among authors: nadal d. J Immunol. 2013 Nov 15;191(10):4989-95. doi: 10.4049/jimmunol.1301046. Epub 2013 Oct 9. J Immunol. 2013. PMID: 24108698 Free PMC article.

3

Role for early-differentiated natural killer cells in infectious mononucleosis.

Azzi T, Lünemann A, Murer A, Ueda S, Béziat V, Malmberg KJ, Staubli G, Gysin C, Berger C, Münz C, Chijioke O, Nadal D. Azzi T, et al. Among authors: nadal d. Blood. 2014 Oct 16;124(16):2533-43. doi: 10.1182/blood-2014-01-553024. Epub 2014 Sep 9. Blood. 2014. PMID: 25205117 Free PMC article.

4

Tonsillar CD56brightNKG2A+ NK cells restrict primary Epstein-Barr virus infection in B cells via IFN-γ.

Jud A, Kotur M, Berger C, Gysin C, Nadal D, Lünemann A. Jud A, et al. Among authors: nadal d. Oncotarget. 2017 Jan 24;8(4):6130-6141. doi: 10.18632/oncotarget.14045. Oncotarget. 2017. PMID: 28008151 Free PMC article.

5

IRAK4 is essential for TLR9-induced suppression of Epstein-Barr virus BZLF1 transcription in Akata Burkitt's lymphoma cells.

Jordi M, Marty J, Mordasini V, Lünemann A, McComb S, Bernasconi M, Nadal D. Jordi M, et al. Among authors: nadal d. PLoS One. 2017 Oct 31;12(10):e0186614. doi: 10.1371/journal.pone.0186614. eCollection 2017. PLoS One. 2017. PMID: 29088270 Free PMC article.

6

Innate immune responses against Epstein Barr virus infection.

Chijioke O, Azzi T, Nadal D, Münz C. Chijioke O, et al. Among authors: nadal d. J Leukoc Biol. 2013 Dec;94(6):1185-90. doi: 10.1189/jlb.0313173. Epub 2013 Jun 28. J Leukoc Biol. 2013. PMID: 23812328 Free PMC article. Review.

7

Immune activation suppresses initiation of lytic Epstein-Barr virus infection.

Ladell K, Dorner M, Zauner L, Berger C, Zucol F, Bernasconi M, Niggli FK, Speck RF, Nadal D. Ladell K, et al. Among authors: nadal d. Cell Microbiol. 2007 Aug;9(8):2055-69. doi: 10.1111/j.1462-5822.2007.00937.x. Epub 2007 Apr 5. Cell Microbiol. 2007. PMID: 17419714

8

Role of latent membrane protein 2 isoforms in Epstein-Barr virus latency.

Rechsteiner MP, Bernasconi M, Berger C, Nadal D. Rechsteiner MP, et al. Among authors: nadal d. Trends Microbiol. 2008 Nov;16(11):520-7. doi: 10.1016/j.tim.2008.08.007. Epub 2008 Oct 3. Trends Microbiol. 2008. PMID: 18835714

9

Activation of ATR-Chk1 pathway facilitates EBV-mediated transformation of primary tonsillar B-cells.

Mordasini V, Ueda S, Aslandogmus R, Berger C, Gysin C, Hühn D, Sartori AA, Bernasconi M, Nadal D. Mordasini V, et al. Among authors: nadal d. Oncotarget. 2017 Jan 24;8(4):6461-6474. doi: 10.18632/oncotarget.14120. Oncotarget. 2017. PMID: 28031537 Free PMC article.

10

Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and γδ T cells.

Djaoud Z, Guethlein LA, Horowitz A, Azzi T, Nemat-Gorgani N, Olive D, Nadal D, Norman PJ, Münz C, Parham P. Djaoud Z, et al. Among authors: nadal d. J Exp Med. 2017 Jun 5;214(6):1827-1841. doi: 10.1084/jem.20161017. Epub 2017 May 3. J Exp Med. 2017. PMID: 28468758 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

471 results

Search Page